The post-modern world of Alzheimer's disease trials: how much is an ADAS-cog point worth in central London?
Schneider
Lon S
LS
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000191:economics; D015982:Bias; D002800:Cholinesterase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards; D003362:Cost-Benefit Analysis / Q000379:methods; D006801:Humans; D017410:Practice Guidelines as Topic; D013222:State Medicine / Q000191:economics; D006113:United Kingdom
D002800:Cholinesterase Inhibitors